203 related articles for article (PubMed ID: 7879701)
1. Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats.
Desai JK; Parmar NS
Agents Actions; 1994 Oct; 42(3-4):149-53. PubMed ID: 7879701
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dopamine receptor subtypes involved in experimentally induced gastric and duodenal ulcers in rats.
Desai JK; Goyal RK; Parmar NS
J Pharm Pharmacol; 1999 Feb; 51(2):187-92. PubMed ID: 10217318
[TBL] [Abstract][Full Text] [Related]
3. Gastric and duodenal anti-ulcer activity of SKF 38393, a dopamine D1-receptor agonist in rats.
Desai JK; Goyal RK; Parmar NS
J Pharm Pharmacol; 1995 Sep; 47(9):734-8. PubMed ID: 8583385
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
[TBL] [Abstract][Full Text] [Related]
5. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
6. Differential response of A 68930 and sulpiride in stress-induced gastric ulcers in rats.
Rasheed N; Ahmad A; Singh N; Singh P; Mishra V; Banu N; Lohani M; Sharma S; Palit G
Eur J Pharmacol; 2010 Sep; 643(1):121-8. PubMed ID: 20599913
[TBL] [Abstract][Full Text] [Related]
7. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
9. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
Tariq M; Parmar NS; Ageel AM
J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
11. Gastric antisecretory, gastric and duodenal anti-ulcer and cytoprotective properties of Ro 22-6923, a synthetic trimethyl prostanoid in rats.
Parmar NS; Tariq M; Ageel AM
Prostaglandins Leukot Med; 1986 Oct; 24(2-3):255-67. PubMed ID: 3467380
[TBL] [Abstract][Full Text] [Related]
12. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
[TBL] [Abstract][Full Text] [Related]
13. Effect of elcatonin on experimental gastric and duodenal ulcers.
Ohno H; Noguchi M; Takayanagi N
Jpn J Pharmacol; 1985 Jan; 37(1):67-75. PubMed ID: 4039385
[TBL] [Abstract][Full Text] [Related]
14. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
15. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
[TBL] [Abstract][Full Text] [Related]
16. Anti-ulcer activity of cromakalim (BRL 34915), a potassium-channel opener, against experimentally induced gastric and duodenal ulcers in rats and guinea-pigs.
Goswami S; Jain S; Santani D
J Pharm Pharmacol; 1997 Feb; 49(2):195-9. PubMed ID: 9055194
[TBL] [Abstract][Full Text] [Related]
17. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
19. Biochemical studies on the anti-ulcerogenic potential of Hemidesmus indicus R.Br. var. indicus.
Anoop A; Jegadeesan M
J Ethnopharmacol; 2003 Feb; 84(2-3):149-56. PubMed ID: 12648808
[TBL] [Abstract][Full Text] [Related]
20. Insights in the mechanisms underlying the anti-ulcer activity of nicorandil.
Ismail HA; Khalifa MM; Hassan MK; Ashour OM
Pharmazie; 2007 Jan; 62(1):60-6. PubMed ID: 17294816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
